Overall rank by patents
#25,618
Across all tracked assignees
USPTO 2015–2025 USPTO PatentsView US Corporation
410 Medical, Inc.
USPTO PatentsView assignee record - 10 granted patents across 7 technology areas, active 2018–2024. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: A61M (DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY ; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY ; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR).
10
Total patents granted
7
CPC technology areas
23.9
Avg claims per patent
+133%
5-year filing velocity
The verdict
410 holds 10 US patents across 7 technology areas, rank #25,618 of 50,000 tracked assignees.
- #25,618
- of 50,000 US assignees by volume
- Top 36%
- by Innovation Score (40.3/100)
- 23.9
- avg claims per patent
- +133%
- filing velocity, last 5 yrs
Portfolio overview
410 Medical, Inc. has been granted 10 US utility patents between 2018 and 2024, placing 410 Medical, Inc. at rank #25,618 across all assignees tracked by PlainPatent. This portfolio spans 7 distinct Cooperative Patent Classification (CPC) subclasses, averaging 23.9 claims per patent with primary concentration in A61M (DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY ; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY ; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR). As a US Corporation, 410 Medical, Inc. is one of the more focused assignees in the PatentsView dataset. By volume, 410 sits between 1ST Biotherapeutics, Inc. (10 patents, rank #25,614) and 9155-0020 Quebec Inc. (10 patents, rank #25,622) - the closest US assignees by grant volume. The composite Innovation Score of 40.3/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Filing cadence tells the strategic story. Between 2020 and 2025 the company received 7 grants, compared with 3 in the 2015–2019 window, a +133% shift in five-year velocity. An acceleration of this magnitude signals aggressive R&D investment and expanding technical ambition. The US Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.
Claim depth and technology breadth together indicate competitive posture. 410 Medical, Inc.'s 23.9 average claims per patent reflects complex, broadly scoped inventions that are difficult for competitors to design around, while concentration in 7 subclasses points to a focused technical program. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark 410 Medical, Inc. against peers pursuing similar technology classes.
Who files at 410's volume?
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
- 1ST Biotherapeuti…
1ST BIOTHERAPEUTICS, INC.
10 patents
- 1st Defence Indus…
1st Defence Industries Ltd.
10 patents
- 2nd Skull
2nd Skull, Inc.
10 patents
- 3D PLUS
3D PLUS
10 patents
- 4DS Memory
4DS MEMORY, LIMITED
10 patents
- 7tunnels
7Tunnels Inc.
10 patents
- 80 Percent Arms
80 Percent Arms Inc.
10 patents
- 9155-0020 Quebec
9155-0020 Quebec Inc.
10 patents
- 410 Medical ◀
410 Medical, Inc.
10 patents
What this shows 410 holds 10 patents at rank #25,618, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
410's Innovation Score vs. every tracked assignee
Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)
40 Top 36% higher than 64% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Grants by year
Teal-shaded recent years (2020–present) versus the 2018–2019 baseline. Full figures in the table below.
View data table
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2018 | 1 | 10.0% |
| 2019 | 2 | 20.0% |
| 2020 | 2 | 20.0% |
| 2022 | 1 | 10.0% |
| 2023 | 2 | 20.0% |
| 2024 | 2 | 20.0% |
Which technologies does 410 Medical, Inc. patent most?
Top 7 of 7 technology areas
Patent Moat Analysis
Portfolio Volume Light
Tech Breadth Focused
Claim Depth Complex
Velocity Accelerating
Frequently Asked Questions
How many patents does 410 Medical, Inc. hold?
410 Medical, Inc. holds 10 US granted patents filed between 2018 and 2024, spanning 7 technology areas.
What is 410 Medical, Inc.'s Innovation Score?
410 Medical, Inc. has an Innovation Score of 40.3 out of 100. This composite metric weighs portfolio volume (40%), filing velocity (20%), technology breadth (25%), and claim depth (15%).
What technology areas does 410 Medical, Inc. focus on?
410 Medical, Inc.'s top technology area is A61M (DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY ; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY ; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR) with 10 patents. The company has filed patents in 7 CPC subclasses total.
Is 410 Medical, Inc.'s patent filing rate increasing or decreasing?
410 Medical, Inc.'s recent filing velocity is +133% compared to the prior five-year period. This indicates accelerating innovation.
What does claim depth mean for 410 Medical, Inc.'s patents?
410 Medical, Inc.'s patents average 23.9 claims each. This indicates complex, broadly scoped patents that are harder for competitors to design around.
How is the 410 Medical, Inc. patent data sourced?
All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.
How to use this portfolio
410's 10 grants land it in the top 36% by Innovation Score, but volume alone doesn't tell you where the strength sits.
- Read that count against the largest US assignees before treating it as dominance - 410 ranks #25,618 of 50,000. Top 50 holders
- Most of this portfolio concentrates in A61M - see who else leads that technology area. A61M leaders
- Check what the four-part Innovation Score actually rewards before comparing it to another company. How the score works
Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.